Impact on Medication Use
’, pain
PAINFUL PERIODS
During their participation, patients were free to use concomitant rescue pain medications as usual considering that the device efficacy may differ between participants. The objective was to evaluate patients’ adherence to a DTx, the integration of the device in their daily routine care, and its impact on pain medication intake. Unfortunately, only short-term data were collected and additional investigations would be needed to also demonstrate a long-term impact of the DTx on long-term medication use habits. Nevertheless, at equivalent medication use between groups, higher pain reduction was observed with Endocare.Compared to baseline levels, patients declared increased use of medications. This was an expected result, as day 1 represents the patient’s first day of painful periods when they need pain relief the most. Despite the lack of difference in medication intake observed between the groups, looking at the analgesics used by the women to relieve their pain, the percentage of patients using any kind of analgesic medication decreased in the Endocare group by 14.7% (41.2% to 26.5%) against only 3.3% (37.3% to 34.0%) in the control group between day 1 and day 2 (